DMK PHARMACEUTICALS CORPORATION: cash_and_restricted_cash
| Value | {"amount": 10506021, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/999189d7-52d0-41a9-a2a2-935938bed7ae
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-20-004946 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cash-and-restricted-cash/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/999189d7-52d0-41a9-a2a2-935938bed7ae
History
- no predecessors — first report